X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1106) 1106
Publication (101) 101
Dissertation (32) 32
Book Review (4) 4
Conference Proceeding (4) 4
Book Chapter (1) 1
Government Document (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
g2/m arrest (628) 628
humans (600) 600
apoptosis (598) 598
index medicus (523) 523
cell cycle (336) 336
oncology (323) 323
cell line, tumor (296) 296
apoptosis - drug effects (246) 246
cell biology (227) 227
biochemistry & molecular biology (222) 222
animals (207) 207
cancer (199) 199
phosphorylation (197) 197
p53 (177) 177
dna damage (164) 164
cell proliferation - drug effects (163) 163
antineoplastic agents - pharmacology (157) 157
dna-damage (153) 153
activation (151) 151
cell cycle - drug effects (144) 144
expression (143) 143
flow cytometry (139) 139
mice (133) 133
proteins (131) 131
pharmacology & pharmacy (127) 127
g2 phase - drug effects (125) 125
female (124) 124
m arrest (122) 122
kinases (115) 115
growth (111) 111
inhibition (111) 111
analysis (108) 108
cell division - drug effects (107) 107
in-vitro (104) 104
cycle arrest (100) 100
g2/m phase arrest (90) 90
blotting, western (88) 88
cancer cells (88) 88
g2 phase cell cycle checkpoints - drug effects (88) 88
cell proliferation (87) 87
male (87) 87
research (87) 87
cell cycle proteins - metabolism (83) 83
death (83) 83
proliferation (83) 83
dose-response relationship, drug (80) 80
cell survival - drug effects (79) 79
mitosis (79) 79
cyclin b1 (78) 78
signal transduction (78) 78
toxicology (78) 78
tumor suppressor protein p53 - metabolism (78) 78
chemistry, medicinal (76) 76
induction (75) 75
g2/m phase (74) 74
chemotherapy (71) 71
tumor cells, cultured (71) 71
down-regulation (69) 69
g2/m (69) 69
protein (69) 69
dna repair (66) 66
genetics & heredity (66) 66
signal transduction - drug effects (64) 64
care and treatment (63) 63
cell cycle checkpoints - drug effects (63) 63
deoxyribonucleic acid--dna (62) 62
g2/m transition (62) 62
cell division (61) 61
kinase (61) 61
protein-serine-threonine kinases - metabolism (60) 60
breast cancer (59) 59
antineoplastic agents, phytogenic - pharmacology (58) 58
cancer-cells (58) 58
cytotoxicity (58) 58
gene expression (58) 58
cell growth (55) 55
cell-cycle (55) 55
g2/m checkpoint (55) 55
pathway (55) 55
cancer therapies (53) 53
hela cells (53) 53
p21 (53) 53
cycle (52) 52
health aspects (51) 51
medicine, research & experimental (51) 51
studies (51) 51
article (50) 50
cell line (50) 50
mitosis - drug effects (50) 50
saccharomyces-cerevisiae (50) 50
cdc2 protein kinase - metabolism (49) 49
dna (49) 49
g2 phase (49) 49
arrest (47) 47
checkpoint (47) 47
protein-kinase (46) 46
mice, nude (45) 45
oxidative stress (45) 45
biophysics (44) 44
carcinoma-cells (44) 44
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 2009, Volume 77, Issue 5, pp. 770 - 780
Journal Article
British Journal of Cancer, ISSN 0007-0920, 05/2009, Volume 100, Issue 9, pp. 1425 - 1433
Curcumin has been shown to inhibit the growth of various types of cancer cells; however, at concentrations much above the clinically achievable levels in... 
Curcumin | Chk1 | G2/M arrest | DNA damage | Pancreatic cancer | CARCINOMA-CELLS | DNA-DAMAGE | DOWN-REGULATION | REGULATED GENE-PRODUCTS | FACTOR-KAPPA-B | BENZYL ISOTHIOCYANATE | I CLINICAL-TRIAL | pancreatic cancer | ONCOLOGY | PROSTATE-CANCER | CHEMOPREVENTIVE AGENT | curcumin | Cell Cycle Proteins - drug effects | Protein Kinases - metabolism | Gene Expression Regulation, Enzymologic - drug effects | Protein Kinases - genetics | Gene Silencing - drug effects | Apoptosis - drug effects | Humans | Caspase 3 - metabolism | Collagen Type XI - metabolism | DNA-Binding Proteins - metabolism | Pancreatic Neoplasms - drug therapy | Transfection | Tumor Suppressor Proteins - genetics | Caspase 3 - drug effects | Cell Cycle Proteins - genetics | Gene Expression Regulation, Neoplastic - drug effects | Protein-Serine-Threonine Kinases - metabolism | DNA Damage - drug effects | Protein Kinases - drug effects | Tumor Suppressor Proteins - metabolism | Collagen Type XI - drug effects | Pancreatic Neoplasms - pathology | Cell Cycle Proteins - metabolism | Curcumin - pharmacology | DNA-Binding Proteins - drug effects | Pancreatic Neoplasms - enzymology | Protein-Serine-Threonine Kinases - genetics | Ataxia Telangiectasia Mutated Proteins | DNA-Binding Proteins - genetics | Cell Division - drug effects | Protein-Serine-Threonine Kinases - drug effects | Cell Line, Tumor | Checkpoint Kinase 1 | Tumor Suppressor Proteins - drug effects | Cell Cycle - drug effects | Translational Therapeutics | M arrest
Journal Article
Journal Article
Cell Death and Differentiation, ISSN 1350-9047, 09/2010, Volume 17, Issue 9, pp. 1511 - 1523
  G-protein-coupled receptor-30 (GPR30) shows estrogen-binding affinity and mediates non-genomic signaling of estrogen to regulate cell growth. We here showed... 
G-protein-coupled receptor-30 | G2/M | signal transduction | non-genomic estrogen signaling | 1-[4-(6-bromobenzo[1,3]dioxol-5yl)-3a,4,5,9b- tetrahydro-3H-cyclopenta[c]quinolin-8-yl]-ethanone
Journal Article
Journal Article
Oncology Letters, ISSN 1792-1074, 01/2015, Volume 9, Issue 1, pp. 136 - 142
CKD-602 (7-[2-(N-isopropylamino) ethyl]-(20S)-camptothecin, belotecan) is a synthetic water-soluble camptothecin derivative and topoisomerase I inhibitor that... 
Oral squamous cell carcinoma | G2/M arrest | CKD-602 | Apoptosis | COMPLEX | KINASE | apoptosis | oral squamous cell carcinoma | HUMAN MYT1 | P53 | INACTIVATION | ONCOLOGY | CAMPTOTHECIN | DNA TOPOISOMERASES | M arrest | IONIZING-RADIATION | INHIBITOR | EXPRESSION
Journal Article
Journal of Cellular and Molecular Medicine, ISSN 1582-1838, 10/2015, Volume 19, Issue 10, pp. 2365 - 2374
2‐Methoxyestradiol (ME), one of the most widely investigated A‐ring‐modified metabolites of estrone, exerts significant anticancer activity on numerous cancer... 
homoestrone | Cdc25B and C | tubulin polymerization | HeLa cells | intrinsic apoptotic pathway | loss of function of Cdk1 | cell cycle arrest | stathmin | G2/M phase transition | Stathmin | d-homoestrone | Cell cycle arrest | Loss of function of Cdk1 | Intrinsic apoptotic pathway | Tubulin polymerization | MEDICINE, RESEARCH & EXPERIMENTAL | APOPTOSIS | DOWN-REGULATION | PROLIFERATION | CANCER | CDC25B PHOSPHATASE | PACLITAXEL | CELL BIOLOGY | M phase transition | GROWTH | 2-METHOXYESTRADIOL | EXPRESSION | PROGRESSION | CDC2 Protein Kinase | Caspase 9 - metabolism | Cyclin-Dependent Kinases - metabolism | Apoptosis - drug effects | Humans | Caspase 8 - metabolism | Uterine Cervical Neoplasms - pathology | RNA, Messenger - metabolism | Polymerization - drug effects | Tubulin - metabolism | G2 Phase Cell Cycle Checkpoints - drug effects | Female | Gene Expression Regulation, Neoplastic - drug effects | Phosphorylation - drug effects | Estrone - pharmacology | Uterine Cervical Neoplasms - enzymology | RNA, Messenger - genetics | Estrone - analogs & derivatives | Mitosis - drug effects | Signal Transduction - drug effects | Estrone - chemistry | Cyclin B - metabolism | Cell Proliferation - drug effects | HeLa Cells | Kinetics | Polymerization | Tubulins | Cervical cancer | Cell cycle | Kinases | Cyclin-dependent kinases | Apoptosis | Cell proliferation | Cell culture | Mitosis | Inactivation | Cancer therapies | Experiments | Phase transitions | Anticancer properties | Human papillomavirus | Tubulin | Metabolites | Cyclin B | Cervical carcinoma | Deactivation | Industrialized nations | Caspase | Breast cancer | Tumor cell lines | Cervix | Organic chemistry | Cell lines | Estrone | Antitumor activity | Disruption | Intracellular | Binding sites | Original
Journal Article
Journal of Experimental and Clinical Cancer Research, ISSN 1756-9966, 05/2018, Volume 37, Issue 1, pp. 98 - 12
Journal Article